DE60231911D1 - Sedierende und nicht sedierende antihistamine enthaltende zusammensetzungen - Google Patents

Sedierende und nicht sedierende antihistamine enthaltende zusammensetzungen

Info

Publication number
DE60231911D1
DE60231911D1 DE60231911T DE60231911T DE60231911D1 DE 60231911 D1 DE60231911 D1 DE 60231911D1 DE 60231911 T DE60231911 T DE 60231911T DE 60231911 T DE60231911 T DE 60231911T DE 60231911 D1 DE60231911 D1 DE 60231911D1
Authority
DE
Germany
Prior art keywords
antihistamine
compositions
release form
sedating
sedative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60231911T
Other languages
English (en)
Inventor
Mark Hirsh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Collegium Pharmaceutical Inc
Original Assignee
Collegium Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Collegium Pharmaceutical Inc filed Critical Collegium Pharmaceutical Inc
Application granted granted Critical
Publication of DE60231911D1 publication Critical patent/DE60231911D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE60231911T 2001-12-05 2002-12-03 Sedierende und nicht sedierende antihistamine enthaltende zusammensetzungen Expired - Lifetime DE60231911D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/012,202 US6827946B2 (en) 2001-12-05 2001-12-05 Compositions containing both sedative and non-sedative antihistamines
PCT/US2002/038544 WO2003049680A2 (en) 2001-12-05 2002-12-03 Compositions containing both sedative and non-sedative antihistamines

Publications (1)

Publication Number Publication Date
DE60231911D1 true DE60231911D1 (de) 2009-05-20

Family

ID=21753834

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60231911T Expired - Lifetime DE60231911D1 (de) 2001-12-05 2002-12-03 Sedierende und nicht sedierende antihistamine enthaltende zusammensetzungen

Country Status (9)

Country Link
US (2) US6827946B2 (de)
EP (1) EP1461015B1 (de)
JP (1) JP2005511711A (de)
AT (1) ATE427740T1 (de)
AU (1) AU2002360462A1 (de)
CA (1) CA2469369C (de)
DE (1) DE60231911D1 (de)
ES (1) ES2333308T3 (de)
WO (1) WO2003049680A2 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0128674D0 (en) * 2001-11-30 2002-01-23 Boots Co Plc Treatment of sleep disorders and the like
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20050152967A1 (en) * 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
JP5021155B2 (ja) * 2003-08-01 2012-09-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング エピナスチンと１種以上のさらなる抗−ｈ１−ヒスタミン類との組合せを含む皮膚疾患治療用製薬組成物
US7972625B2 (en) * 2003-09-24 2011-07-05 Novartis Ag Coated diclofenac tablets
US7115610B2 (en) * 2003-12-18 2006-10-03 Cv Therapeutics, Inc. Substituted heterocyclic compounds
JP2005325070A (ja) * 2004-05-14 2005-11-24 Ss Pharmaceut Co Ltd 睡眠改善剤
NL1026634C2 (nl) * 2004-07-12 2006-01-16 Willem Jacob Van Der Burg Psychofarmaceutisch preparaat en werkzame stof daarin.
US9592197B2 (en) * 2004-12-16 2017-03-14 Sovereign Pharmaceuticals, Llc Dosage form containing diphenhydramine and another drug
US20070003622A1 (en) * 2004-12-16 2007-01-04 Sovereign Pharmaceuticals, Ltd. Diphenhydramine containing dosage form
US20080095842A1 (en) * 2004-12-06 2008-04-24 Antarkar Amit K Rapidly Disintegrating Taste Masked Compositions and a Process for Its Preparations
JP5004236B2 (ja) * 2005-02-09 2012-08-22 キッセイ薬品工業株式会社 口腔内崩壊錠
US7529255B2 (en) * 2005-04-21 2009-05-05 Microsoft Corporation Peer-to-peer multicasting using multiple transport protocols
US20070048373A1 (en) * 2005-08-30 2007-03-01 Cima Labs Inc. Dried milled granulate and methods
US20070253927A1 (en) * 2006-04-13 2007-11-01 Gwenaelle Jegou Cosmetic compositions comprising at least one dielectrophile monomer and at least one radical initiator
AU2007254826B2 (en) * 2006-06-01 2013-10-24 Merck Sharp & Dohme Corp. Pharmaceutical compositions for sustained release of phenyephrine
SG172664A1 (en) * 2006-06-01 2011-07-28 Schering Plough Healthcare Phenylephrine pharmaceutical formulations and compositions for colonic absorption
US20080015241A1 (en) * 2006-07-13 2008-01-17 Cornerstone Biopharma, Inc. All day rhinitic condition treatment regimen
US20080311196A1 (en) * 2006-07-13 2008-12-18 White Donna F All Day Rhinitic Condition Treatment Regimen
US8653066B2 (en) 2006-10-09 2014-02-18 Charleston Laboratories, Inc. Pharmaceutical compositions
EP2091515B1 (de) * 2006-11-21 2014-06-04 McNeil-PPC, Inc. Analgetische suspensionen mit modifizierter freisetzung
WO2008105920A1 (en) * 2007-02-28 2008-09-04 Collegium Pharmaceutical, Inc. Antihistamine combination
US8703204B2 (en) 2007-05-03 2014-04-22 Bend Research, Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
US8309129B2 (en) 2007-05-03 2012-11-13 Bend Research, Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
US8071119B2 (en) * 2007-05-14 2011-12-06 Sustained Nano Systems Llc Controlled release implantable dispensing device and method
CA2704111C (en) * 2007-05-14 2017-06-20 Sustained Nano Systems Llc Hypercompressed particles for controlled release of ophthalmic medications
US20090148498A1 (en) * 2007-05-14 2009-06-11 Sustained Nano Systems Llc Controlled release implantable dispensing device and method
WO2008149192A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
US9545384B2 (en) 2007-06-04 2017-01-17 Bend Research, Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
US9833510B2 (en) * 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
EP2222299B1 (de) * 2007-11-19 2011-11-23 Bausch & Lomb Incorporated Verwendung von levocabastin zur modulierung der erzeugung von proinflammatorischen zytokinen
US9233078B2 (en) 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
US9724362B2 (en) 2007-12-06 2017-08-08 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
HUE029444T2 (en) * 2008-01-04 2017-02-28 Schabar Res Ass Llc A composition containing an analgesic and an antihistamine
EP2240022B1 (de) 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Oxycodone und Promethazine enthaltende zweischichtige Tabletten
WO2009094457A2 (en) * 2008-01-22 2009-07-30 Auspex Pharmaceuticals Substituted benzhydrylethers
EP2408302A4 (de) * 2009-03-17 2012-08-15 Aciex Therapeutics Inc Ophthalmische formulierungen aus ketotifen und verfahren zu ihrer verwendung
EP3943069A1 (de) 2009-03-17 2022-01-26 Nicox Ophthalmics, Inc. Ophthalmische formulierungen aus cetirizin und verfahren zu ihrer verwendung
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
WO2011006012A1 (en) 2009-07-08 2011-01-13 Charleston Laboratories Inc. Pharmaceutical compositions
JP2013119540A (ja) * 2011-12-08 2013-06-17 Nipro Corp 固形医薬組成物およびその製造法
CN103251591B (zh) * 2013-05-13 2014-12-17 中国科学院武汉病毒研究所 一种吡拉明马来酸盐在制备治疗或预防流感病毒药物中的应用
WO2014189933A1 (en) * 2013-05-22 2014-11-27 Empire Technology Development Llc Long delayed release laxative
MX2017003556A (es) 2014-09-19 2017-07-14 Procter & Gamble Formas de dosificacion de fenilefrina de liberacion pulsada.
CN105527177B (zh) * 2016-01-11 2016-11-16 中国人民解放军理工大学 一种深部岩体爆炸地冲击扰动模拟试验方法及装置
US10064820B2 (en) 2016-09-30 2018-09-04 Aptapharma Inc. Antihistamine compositions, combinations, and use thereof
US10278930B2 (en) 2017-03-16 2019-05-07 The Procter & Gamble Company Method for relieving sinus congestion
CN111032059A (zh) * 2017-06-27 2020-04-17 哈莫尼克斯有限公司 延时释放睡眠辅助系统
JP2020015690A (ja) * 2018-07-25 2020-01-30 ニプロ株式会社 レボセチリジン含有錠剤
JP7271869B2 (ja) * 2018-07-25 2023-05-12 ニプロ株式会社 レボセチリジン含有錠剤
CN110870864B (zh) * 2018-08-29 2021-09-24 复旦大学 马来酸卡比沙明在制备抗流感病毒药物中的应用
WO2022015784A1 (en) 2020-07-15 2022-01-20 Schabar Research Associates Llc Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn
US11324727B2 (en) 2020-07-15 2022-05-10 Schabar Research Associates, Llc Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2297599A (en) 1940-09-28 1942-09-29 Squibb & Sons Inc Effervescent tablet
GB800973A (en) 1954-08-13 1958-09-03 Sterling Drug Inc Improvements in or relating to pills or tablets
US4004036A (en) 1966-05-31 1977-01-18 Alberto Culver Company Effervescent molded triturate tablets
US3898323A (en) 1970-04-15 1975-08-05 Mirlin Corp Taste modifying composition
US3873727A (en) 1971-06-01 1975-03-25 Parke Davis & Co Stabilization of molded sublingual nitroglycerin tablets
US4139589A (en) 1975-02-26 1979-02-13 Monique Beringer Process for the manufacture of a multi-zone tablet and tablet manufactured by this process
US4229447A (en) 1979-06-04 1980-10-21 American Home Products Corporation Intraoral methods of using benzodiazepines
CA1163561A (en) 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
NL8100259A (nl) 1980-01-21 1981-08-17 Wellcome Found Combinaties van ketonen met heterocyclische verbindingen, famaceutische preparaten welke deze bevatten, werkwijze om dergelijke preparaten te bereiden en toepassing daarvan in de geneeskunde.
US4552899A (en) 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4783465A (en) 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
GB8430346D0 (en) 1984-11-30 1985-01-09 Reckitt & Colmann Prod Ltd Analgesic compositions
US4814181A (en) 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US5082667A (en) 1988-06-07 1992-01-21 Abbott Laboratories Solid pharmaceutical dosage in tablet triturate form and method of producing same
US5776493A (en) 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
US5021053A (en) 1989-07-14 1991-06-04 Alza Corporation Oral osmotic device with hydrogel driving member
US5739136A (en) 1989-10-17 1998-04-14 Ellinwood, Jr.; Everett H. Intraoral dosing method of administering medicaments
US5064656A (en) 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
US5156850A (en) 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
WO1992015332A1 (en) 1991-03-04 1992-09-17 Warner-Lambert Company Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
JP2771911B2 (ja) 1991-08-09 1998-07-02 三菱電機株式会社 車載用ナビゲーション装置
US5407686A (en) 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5248310A (en) 1992-03-27 1993-09-28 Alza Corporation Oral osmotic device with hydrogel driving member
US5512299A (en) 1992-03-30 1996-04-30 Alza Corporation Method of treating oral inflammatory disease
US5294433A (en) 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
US5512293A (en) 1992-07-23 1996-04-30 Alza Corporation Oral sustained release drug delivery device
ES2051658T3 (es) 1992-08-06 1998-06-16 Gergely Gerhard Comprimidos efervescentes faciles de administrar.
US5609884A (en) 1992-08-31 1997-03-11 G. D. Searle & Co. Controlled release naproxen sodium plus naproxen combination tablet
JPH08501083A (ja) 1992-09-03 1996-02-06 セプラコア インコーポレーテッド アレルギー疾患治療のためのノルアステミゾールの使用
US5314697A (en) 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5573776A (en) 1992-12-02 1996-11-12 Alza Corporation Oral osmotic device with hydrogel driving member
US5368588A (en) 1993-02-26 1994-11-29 Bettinger; David S. Parenteral fluid medication reservoir pump
US5284298A (en) * 1993-04-13 1994-02-08 Fluid Controls Inc. Fluid-conducting swivel and method
CA2161217A1 (en) * 1993-04-30 1994-11-10 Carmelita Macklin Russell Coated pharmaceutical compositions
US5362496A (en) 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US6183778B1 (en) 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
US5407339A (en) 1993-09-27 1995-04-18 Vector Corporation Triturate tablet machine
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
US5702723A (en) 1994-08-02 1997-12-30 Griffin; David Multi-stage delivery system for ingestible medications or nutrients
US5827180A (en) 1994-11-07 1998-10-27 Lifemasters Supported Selfcare Method and apparatus for a personal health network
US5595997A (en) 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US5656284A (en) 1995-04-24 1997-08-12 Balkin; Michael S. Oral transmucosal delivery tablet and method of making it
US5558879A (en) 1995-04-28 1996-09-24 Andrx Pharmaceuticals, Inc. Controlled release formulation for water soluble drugs in which a passageway is formed in situ
US5807579A (en) 1995-11-16 1998-09-15 F.H. Faulding & Co. Limited Pseudoephedrine combination pharmaceutical compositions
US5648358A (en) * 1996-03-05 1997-07-15 Mitra; Sekhar Compositions and methods for treating respiratory disorders
WO2000035296A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Improved release of medicament active agents from a chewing gum coating
US5900421A (en) 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
DE19715594A1 (de) 1997-04-15 1998-10-22 Bayer Ag Analgetika-Kombination
DE69818607T2 (de) 1997-05-30 2004-07-29 Osmotica Corp. Mehrlagige osmosevorrichtung
IL133420A (en) 1997-08-26 2004-07-25 Aventis Pharma Inc Tablet-shaped pharmaceutical preparation containing a combination of piperidinoalkanol and antihistamines and reduces symptomatic congestion
US6166037A (en) 1997-08-28 2000-12-26 Merck & Co., Inc. Pyrrolidine and piperidine modulators of chemokine receptor activity
JP2001517626A (ja) * 1997-09-19 2001-10-09 ザ、プロクター、エンド、ギャンブル、カンパニー 呼吸疾患を治療するための組成物及び方法
FR2772615B1 (fr) 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
US6110500A (en) 1998-03-25 2000-08-29 Temple University Coated tablet with long term parabolic and zero-order release kinetics
US6372254B1 (en) 1998-04-02 2002-04-16 Impax Pharmaceuticals Inc. Press coated, pulsatile drug delivery system suitable for oral administration
US6051585A (en) 1998-12-07 2000-04-18 Weinstein; Robert E. Single-dose antihistamine/decongestant formulations for treating rhinitis
US6086914A (en) 1999-03-12 2000-07-11 Weinstein; Robert E. Nonsedating formulations for allergic rhinitis which possess antihistaminic and anticholinergic activity
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
AR031068A1 (es) 1999-04-13 2003-09-10 Beecham Pharm Pte Ltd Una formulacion farmaceutica de liberacion modificada que comprende amoxicilina y clavulanato de potasio en una relacion de 2:1 a 20:1, un comprimido en capas, el uso de la amoxicilina y el clavulanato de potasio para la fabricacion de un medicamento, un equipo y granulos compactos
US6114346A (en) 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
US6572891B1 (en) 1999-10-23 2003-06-03 Alkaloid Ad Sublingual oral dosage form
WO2001037814A1 (en) 1999-11-23 2001-05-31 Robert Gordon University Bilayered buccal tablets comprising nicotine
DE19963319C2 (de) 1999-12-21 2002-02-14 Hennig Arzneimittel Gmbh & Co Orale pharmazeutische Zubereitung
AU2277301A (en) * 1999-12-21 2001-07-03 Schering Corporation Treating allergic and inflammatory conditions
US6602518B2 (en) 2001-06-28 2003-08-05 Wm. Wrigley Jr. Company Chewable product including active ingredient
MXPA04000209A (es) 2001-07-10 2005-03-07 Teva Pharma Sistema de administracion para la administracion de droga de orden cero, bifasica de orden cero, ascendente o descendente.
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines

Also Published As

Publication number Publication date
CA2469369A1 (en) 2003-06-19
ATE427740T1 (de) 2009-04-15
US7585520B2 (en) 2009-09-08
US6827946B2 (en) 2004-12-07
AU2002360462A8 (en) 2003-06-23
US20050069580A1 (en) 2005-03-31
ES2333308T3 (es) 2010-02-19
JP2005511711A (ja) 2005-04-28
CA2469369C (en) 2008-11-18
EP1461015A4 (de) 2007-07-25
WO2003049680A2 (en) 2003-06-19
EP1461015B1 (de) 2009-04-08
EP1461015A2 (de) 2004-09-29
WO2003049680A3 (en) 2003-10-30
US20030130263A1 (en) 2003-07-10
AU2002360462A1 (en) 2003-06-23

Similar Documents

Publication Publication Date Title
ATE427740T1 (de) Sedierende und nicht sedierende antihistamine enthaltende zusammensetzungen
TW200635897A (en) Piperidine derivatives and their use as anti-inflammatory agents
NO20043367L (no) Oralt farmasoytisk preparat
PT1326643E (pt) Inibicao do efeito emetico da metformina com antagonistas de receptores 5-ht3
EP1793827A4 (de) Tricyclische anilid-spirohydantoin-cgrp-rezeptorantagonisten
MXPA05010859A (es) Antagonistas mchr1 heterociclicos.
NO20052739L (no) CCR5-antagonister som medikamenter
AU2003242544A1 (en) New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents
NO20051102L (no) Sulfonylamino-eddiksyre-derivater
BRPI0418112A (pt) inibidores de p-38 quinase bicìclico heterocìclicos
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
WO2006031676A3 (en) Tricyclic anilide spirohydantoin cgrp receptor antagonists
UA86621C2 (ru) Антагонисты рецептора глюкагона, их получение и терапевтическое применение
MA27095A1 (fr) Formes de sels de e-2 -methoxy-n-(3-(4-(3-methyl-pyridine-3-yloxy)-phenylamino)-quinazoline-6-yl)-allyl)-acetamide, leur preparation et leur utilisation contre le cancer
WO2006070325A3 (en) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
TR200101155T2 (tr) 4-Aroil Piperidin CCR-3 Reseptör Antagonistleri III
WO2005082893A3 (en) Histamine h3 receptor antagonists, preparation and therapeutic uses
MXPA04002825A (es) Derivados de quinolina como antagonistas de neuropeptido y.
SG152257A1 (en) Topical preparation containing ambroxol
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
WO2007095091A3 (en) Oral delivery of therapeutic agents using tight junction agonists
UA83868C2 (ru) Производные бензимидазолона и хиназолинона в качестве агонистов человеческих рецепторов orl1
AR038824A1 (es) Composiciones de medicamentos que, junto a agentes colinergicos, contienen compuestos heterociclicos
AU2003226765A1 (en) Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents
MXPA04008460A (es) Composiciones farmaceuticas de un inhibidor de pde4 o pde3/4 y un antagonista de receptor de histamina.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition